The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

Selection frequencies plotted in decreasing order. by Hannah P. Rowe (7830599)

Fig 26 - by Piotr Popik (292215)

Fig 26 - by Zhezhe Zhang (19704587)

Loss of RBM-26 causes mitochondria dysfunction in PLM. by Tamjid A. Chowdhury (14149846)

Loss of RBM-26 function causes a reduction in the density of mitochondria in the PLM axon. by Tamjid A. Chowdhury (14149846)

Interleaved increasing (uneven numbered tones) and decreasing (even numbered tones) series of tones, ISI 26.6ms. by Nathanael Larigaldie (21703267)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

Lateral ventricular wall whole mount immunofluorescence from brains of 2f1 <i>Lrig1</i>^{<em>T2A-iCreERT2/+</em>}<i>; Rosa26</i>^{<em>Ai14/+</em>} mice at 7 days, 1... by Hyung-song Nam (8914220)

“…</p><p>✵</p><p dir="ltr">Whole mounts of lateral ventricular walls from uninduced line 2f1 <i>Lrig1</i>^{<em>T2A-iCreERT2/+</em>}<i>; Rosa26</i>^{<em>Ai14/+</em>} mice to control for tamoxifen-independent labeling (additional information <a href="https://doi.org/10.6084/m9.figshare.12493562.v44" rel="noreferrer" target="_blank">here</a>).…”

RBM-26 binds to the <i>mals-1</i> mRNA and negatively regulates its expression. by Tamjid A. Chowdhury (14149846)

Histogram of number of drugs with (a) increased and (b) decreased usage within 12 months. by Nguyen Thach (20347852)

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Largest changes in influenza vaccine rates, Pre- vs. Post-COVID-19. by Tyler B. Nofzinger (21560244)

Subjects:

Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. by Tamjid A. Chowdhury (14149846)

“…(D) Loss of RBM-26 protein expression causes a decrease in mitoribosome expression, which was assayed with the MitoRibo-Tag system consisting of the MRPL-58 mitoribosomal protein tagged at its C-terminus with 3XFLAG (MRPL-58::3XFLAG). …”

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. by Tamjid A. Chowdhury (14149846)

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…This hypothesis was tested by introducing flexible prototypical phosphenium cations, resulting in an ∼8 kcal/mol decrease in the activation energy for H₂ splitting. …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…This hypothesis was tested by introducing flexible prototypical phosphenium cations, resulting in an ∼8 kcal/mol decrease in the activation energy for H₂ splitting. …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…This hypothesis was tested by introducing flexible prototypical phosphenium cations, resulting in an ∼8 kcal/mol decrease in the activation energy for H₂ splitting. …”

Why Only the 2,6-Bis(o-Carborano)Pyridine-Stabilized Phosphenium Cation Has Succeeded in Splitting H₂?: Key Design Insights for Next-Gen Phosphenium Pincer Catalysts by Mohmmad Faizan (14122382)

“…This hypothesis was tested by introducing flexible prototypical phosphenium cations, resulting in an ∼8 kcal/mol decrease in the activation energy for H₂ splitting. …”